MDM2 and acute myeloid leukemia: For example, a recent study using AML xenograft mouse models reported that MDM2 inhibition can increase MHC-II production, and CD8+ T cells isolated from MDM2 inhibitor-treated primary AML mice can eradicate disease in secondary recipients[35].